Effects of Erigeron Injection on vascular endothelium in patients after intracoronary stenting

Wang Xiao-ying; Miao Feng

doi:10.1007/BF02836519

Your Location：

Home >

Browse articles >

Effects of Erigeron Injection on vascular endothelium in patients after intracoronary stenting

OriginalPaper | Updated：2021-08-27

- Effects of Erigeron Injection on vascular endothelium in patients after intracoronary stenting
- Effects of Erigeron Injection on vascular endothelium in patients after intracoronary stenting
- 中国结合医学杂志（英文版） 2006年12卷第3期页码：185-188
- Affiliations：
  
  Hospital of Zhejiang University,Hangzhou
- Author bio：
- Funds：
- DOI：10.1007/BF02836519
  中图分类号：
- 纸质出版日期：2006，
Scan for full text
Xiao-ying, W., Feng, M. Effects of Erigeron Injection on vascular endothelium in patients after intracoronary stenting., Chin. J. Integr. Med. 12, 185–188 (2006). https://doi.org/10.1007/BF02836519

Wang Xiao-ying, Miao Feng. Effects of Erigeron Injection on vascular endothelium in patients after intracoronary stenting[J]. Chinese Journal of Integrative Medicine, 2006,12(3):185-188.
Xiao-ying, W., Feng, M. Effects of Erigeron Injection on vascular endothelium in patients after intracoronary stenting., Chin. J. Integr. Med. 12, 185–188 (2006). https://doi.org/10.1007/BF02836519 DOI：

Wang Xiao-ying, Miao Feng. Effects of Erigeron Injection on vascular endothelium in patients after intracoronary stenting[J]. Chinese Journal of Integrative Medicine, 2006,12(3):185-188. DOI： 10.1007/BF02836519.

摘要

Objective: To observe the levels of serum C-reactive protein (CRP)

endothelin-1 (ET-1)

nitric oxide (NO)

and superoxide dismutase (SOD) in patients after intracoronary stenting (ICS)

and the effects of Erigeron Injection (EI) on them.Methods: Seventy-two patients

who received ICS and had symptoms of chest stuffiness

palpitation and chest pain

were randomly divided into two groups

with 36 patients in the control group treated with Plavix alone for anti-platelet aggregation

and the other 36 patients in the treated group treated with Plavix and EI in combination. CRP

ET-1

NO and SOD were determined and compared before and 1

2 and 3 weeks after treatment.Results: As compared with those in the control group

improvement of symptoms in the treated group was significantly better

with the levels of CRP and ET-1 lower and levels of SOD and NO higher or approaching to normal ranges and significant difference was shown between the two groups (P < 0.01).Conclusion: EI could alleviate uncomfortable feelings such as chest stuffiness in patients after ICS

and improve the function of vascular endothelium.

Abstract

Objective: To observe the levels of serum C-reactive protein (CRP)

endothelin-1 (ET-1)

nitric oxide (NO)

and superoxide dismutase (SOD) in patients after intracoronary stenting (ICS)

and the effects of Erigeron Injection (EI) on them.Methods: Seventy-two patients

who received ICS and had symptoms of chest stuffiness

palpitation and chest pain

were randomly divided into two groups

with 36 patients in the control group treated with Plavix alone for anti-platelet aggregation

and the other 36 patients in the treated group treated with Plavix and EI in combination. CRP

ET-1

NO and SOD were determined and compared before and 1

2 and 3 weeks after treatment.Results: As compared with those in the control group

improvement of symptoms in the treated group was significantly better

and improve the function of vascular endothelium.

关键词

after intracoronary stentingendothelinC-reactive proteinsuperoxide dismutaseNitric OxideErigeron Injection

Keywords

after intracoronary stentingendothelinC-reactive proteinsuperoxide dismutaseNitric OxideErigeron Injection

references

State Administration of Traditional Chinese Medicine. Trade standard of Peoples Republic of China. 1995: 18–19.

Zhang MZ, Tian WJ, Zou X, et al. Thinking and method of TCM syndrome differentiation depending therapy before and after coronary invention treatment of acute myocardial infarction: analysis on treatment of 70 Patients. Chin J Integr Tradit West Med 2004;7(24): 638–639.

Yu AZ. Li JF, Li GS, et al. A clinical study on the minor myocardial injury associated with percutaneous coronary intervention. J Chin Phys 2004;5(5): 629–630.

Hu DY, Zhao MZ. Therapy level of coronary heart disease in our country. Chin J Pract Intern Med 2005;25 (1): 3–4.

Liu SY, Zhang H, Li YJ, et al. Protective effect and mechanism of Honghua Injection on myocardial ischemia during intervention treatment inpatients with coronary heart diseases. J Heibei Tradit Chin Med Pharmacol 2004;19(4): 29–31.

Ju Y. Significance and change of serum ET, TNF-α and NO in patients with coronary heart disease. Chin J Med Pract 2005;94(1): 122–123.

Zhang J, Li XS, Zhang WD. Progress on chemical ingredients and pharmacological activity of Chinese herbal Erigeronis. J Pharm Pract 2002;2: 156–157.

Shen L, Ji HF, Chai JG. Theoretical assessment on clearing activity of free radical by nine kinds of nature products. Acta Biophys Sin 2005;10(21): 333–335.

Zhong HJ, Deng YJ. Progress on new dosage form of Erigeronis. Chin Tradit Pat Med 2005; (8): 178–179.

FULL TEXT LINK

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Metabolic regulatory and anti-oxidative effects of modified bushen huoxue decoction (补肾活血方) on experimental rabbit model of osteoarthritis

Observation on clinical effect of acupuncture on superoxide dismutase, lipid peroxide and nitric oxide in vascular dementia patients

Observation of clinical effect of acupuncture on vascular dementia and its influence on superoxide dismutase, lipid peroxide and nitric oxide

Effect of Shengmai injection (生脉注射液) on diaphragmatic contractility in doxorubicin-treated rats